Company Filing History:
Years Active: 2008
Title: Mark Noble: Innovator in Polynucleotide Delivery Systems
Introduction
Mark Noble is a distinguished inventor based in Monona, WI (US). He has made significant contributions to the field of biomedical engineering, particularly in the delivery of therapeutic agents to targeted cells. His innovative approach has the potential to enhance treatment options for various medical conditions.
Latest Patents
Mark Noble holds a patent for a process titled "Process for delivery of polynucleotides to the prostate." This patent discloses a system for providing in vivo delivery of polynucleotides to mammalian prostate cells using an intravascular administration route. The method involves inserting polynucleotides in an injection solution into mammalian vasculature. By controlling the rate of insertion, the volume of extravascular fluid in the tissue is increased, thereby facilitating the delivery of the polynucleotide to the target cells. He has 1 patent to his name.
Career Highlights
Mark Noble is currently associated with Mirus Bio Corporation, where he continues to work on innovative solutions in the field of gene delivery. His expertise and dedication to research have positioned him as a valuable asset in the company.
Collaborations
Some of his notable coworkers include James E Hagstrom and Julia Hegge, who contribute to the collaborative environment at Mirus Bio Corporation.
Conclusion
Mark Noble's work in the delivery of polynucleotides represents a significant advancement in medical technology. His innovative patent and ongoing contributions to the field highlight his commitment to improving therapeutic delivery systems.